Evidence mapPaperPMID 41808346Full record

ArticleRenal failure2026

Lactate induces renal lipid accumulation and aggravates renal fibrosis by inhibiting the PPARα signaling pathway and fatty acid oxidation.

Weili Wang, Yilin Gao, Yizhen Chen, Meng Cheng, Liuting Wei, Yonghao Sang, Lei Zhang, Rong Dai, Yiping Wang

Abstract read
In one paragraph

Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Weili WangDepartment of Nephrology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Yilin GaoDepartment of Nephrology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Yizhen ChenDepartment of Nephrology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Meng ChengDepartment of Nephrology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Liuting WeiDepartment of Nephrology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Yonghao SangDepartment of Nephrology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Lei ZhangDepartment of Nephrology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Rong DaiDepartment of Nephrology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Yiping WangDepartment of Nephrology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is characterized by renal fibrosis as its core pathological feature, and lipid metabolism disorders are a key driver of disease progression. However, the specific pathological significance of elevated lactate levels in patients with CKD remains unclear. This study aimed to verify the hypothesis that lactate exacerbates renal fibrosis by inhibiting the PPARα/FAO pathway. A total of 15 healthy controls and 75 CKD patients were enrolled. Serum lactate levels were measured, and their correlations with Scr, BUN, eGFR, and lipid metabolism parameters (triglycerides [TG], total cholesterol [TCH]) were analyzed. Meanwhile, unilateral ureteral obstruction (UUO) mouse models and transforming growth factor-β1 (TGF-β1)-induced human proximal tubular epithelial cells (HK-2 cells) were used to validate the regulatory role of lactate in renal fibrosis. Results showed that serum lactate levels in CKD patients significantly increased with disease stage progression, and were positively correlated with Scr, BUN, TG, and TCH (

Indexed as

Fatty AcidsKidneyLactic AcidLipid MetabolismPPAR alphaRenal Insufficiency, ChronicAdultAnimalsCase-Control StudiesCell LineDisease Models, AnimalDisease ProgressionFemaleFibrosisHumansMaleFatty AcidsLactic AcidPPAR alphaPPARA protein, humanTransforming Growth Factor beta1fatty acid oxidationLactatePPARαrenal fibrosis

Identifiers

PMID41808346
PMCPMC12981269

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.